feed,title,long_url,short_url
Benzinga,Embracer Group Reports 24% Sales Decline In Q1 2024,https://benzinga.com/node/40402649,https://da.gd/mWcwa
Benzinga,"Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside",https://benzinga.com/analyst-ratings/analyst-color/24/08/40402568/oral-vaccine-focused-penny-stock-vaxart-is-uniquely-positioned-analyst-sees-almost-,https://da.gd/hh5Cr
